x
ServiziMenu principaleHome
You are here: Home > Events > Past events > 2014 > 7th ESO-EONS Masterclass in Oncology Nursing
Print

7th ESO-EONS Masterclass in Oncology Nursing

Not eligible for ESCO credits

08.03.2014  -  13.03.2014

Ermatingen, Switzerland

MASTERCLASS

Nursing

Description

Chairs: A. Margulies, CH - L. Sharp, SE
Scientific Co-ordinator: B. Grube, DK



The Masterclass in Oncology Nursing programme is designed for European advanced oncology nurses as a multi-professional joint event. Five intensive days of full immersion in up-to-date oncology will create a collective spirit of teaching and learning to improving clinical skills and patient care. 

Nursing sessions are specific nursing-oriented sessions exploring specialist practice skills such as assessment and decision making, communication skills, complex symptom management, research in nursing, psychosocial consequences of cancer therapy to mention a few.
Other sessions will provide the forum for reviewing and understanding the growing evidence base for nursing interventions and reflect on participant’s role in clinical leadership. Case studies will be presented by the participants and will explore nursing practice focusing on special aspects of care.

In joint clinical sessions, nurses will, together with physicians, update their clinical knowledge about the latest issues for the management of various cancers, with an international faculty of experts. Special joint sessions will highlight and support the growing need for multidisciplinarity in chosen topics.

Practical training will be offered in smaller group optional sessions and coaching groups focusing on skills required for the management of active therapy and follow up. 


AIMS AND OBJECTIVES
The Masterclass aims to prepare oncology nurses for future senior roles and enhance their clinical knowledge in the management of the cancer patient during all phases of the cancer journey. Following completion of the course nurses will be able to use evidence based knowledge in effective symptom management and interventions with the aim to improve patient experience, symptom management and care.

Learning outcomes:

• Understand new developments in oncology disease management.
• Recognise and describe acute and late adverse effects of cancer and its treatment.
• Identify complex patient needs across the diagnostic and oncology treatment trajectory.
• Demonstrate communication skills in managing oncology nursing care.
• Critically appraise the evidence for cancer symptom management and intervention.
• Describe the role of the advanced oncology nurse in leading clinical nursing care.


TEACHING FORMAT
The Masterclass offers plenary lectures regarding state-of-the-art clinical evaluation and treatments with reference to clinical guidelines and which will include notes and resources. Participants will be supported within small groups and discuss personal development plans with tutors in the faculty. Skills based clinical sessions will be interactive and participants must be prepared to join in.

All participants will reside at the course venue and participation in the nursing sessions is compulsory throughout the course.
The Masterclass will be entirely in English and fluency in English is necessary for admission.
Participants of the Masterclass in Nursing Oncology will attend selected medical sessions. Clinical case studies, submitted prior to the course, will be a requirement for all participants. The faculty will evaluate which case studies will be presented for group discussion.


THE MASTERCLASS IS:
• A 5-day residential educational event
• Full immersion
• Clinically-oriented
• Multidisciplinary
• An international faculty of top experts delivering advanced concepts

   

General information

ORGANISING SECRETARIAT
European Oncology Nursing Society
EONS Secretariat
Att. Rudi Brike
E. Mounierlaan 83
1200 Brussels, Belgium
Ph +32 2 779 9923 - Fax +32 2 779 9937
eons.secretariat@cancernurse.eu 


ACCREDITATION
The Masterclass programme will be accredited by the European Oncology Nursing Society.

Faculty list


FACULTY
N. Aaronson
, Antoni van Leeuwenhoek Hospital, Department of Psychosocial Research and Epidemiology, Amsterdam,  NL
A. Arber, Faculty of Health and Medical Sciences, University of Surrey, Guilford, UK
J. Bernier
, Clinique de Genolier, Department of Radiotherapy, Genolier, CH
A. Cervantes, Hospital Clinico Universitario, Department of Medical Oncology, Valencia, ES
A. Costa, European School of Oncology, Milan, IT
G. Curigliano
, European Institute of Oncology, Division of Medical Oncology, Milano, IT
T. Eisen, University of Cambridge, Department of Oncology, Cambridge, UK
S. Faithfull, Faculty of Health and Medical Sciences, University of Surrey, Guilford, UK
C. Faivre-Finn, The Christie NHS Foundation Trust, Department of Clinical Oncology, Manchester, UK
W. Gatzemeier, Humanitas Cancer Center, Breast Unit, Rozzano, IT
B. Grube, Head of Education, Danish Nurses Organisation, DK
A. Hoy, Consultant in Palliative Medicine, Lead for Advanced Communication Skills SWSH, Epsom, UK
D. Kelly
, Chair of Nursing Research,Cardiff University, UK
J.M. Luthi, Thun Hospital, Oncology Center, Thun, CH
A. Margulies, Clinical Oncology Nurse, EONS Executive Board, Zurich, CH
O. Michielin, Lausanne University Hospital - CHUV, Department of Medical Oncology, Lausanne, CH
N. Pavlidis, University Hospital of Ioannina, Division of Medical Oncology, Ioannina, GR
O. Pagani, Oncology Institute of Southern Switzerland (IOSI), Breast Unit, Bellinzona, CH
F.A. Peccatori, European Institute of Oncology, Division Gynecologic Oncology, Milano, IT
G. Pichert, Genetic Consultant for Hereditary Cancer, CH
R. Popescu, Hirslanden Klinik Aarau, Tumor Center - Department of Medical Oncology, Aarau, CH
C. Rothermundt, Kantonsspital St. Gallen, Department of Onkology/Haematology, St. Gallen, CH
D. Sebag-Montefiore, St James' Institute of Oncology - St James' University Hospital, Department of Medical Oncology, Leeds, UK
S. Segaert, University Hospital Sint-Rafaël, Department of Dermatology, Leuven, BE
L. Sharp, Karolinska University Hospital, Department of Oncology, Stockholm, SE
R.A. Stahel, University Hospital Zurich, Clinic for Oncology, Zurich, CH
E. Van Cutsem,  University Hospital Gasthuisberg, Department of Internal Medicine, Leuven, BE
E. van Muilekom, Clincal Nurse Specialist, Netherlands Cancer Institute-Antoni van Leeuwenhoek hospital, The Netherlands
W. Weder, University Hospital Zurich, Division of Thoracic Surgery, Zurich, CH
M. Weller, University Hospital Zurich, Department of Neurology, Zurich, CH
E.M. Wells, NMH Research, University of Stirling, Stirling Scotland, UK



.

Programme


8 March

  12:30Lunch         
  14:00Focus on ESO and on ESMO   
A. Costa, IT - R.A. Stahel, CH
  14:30

Greeting and introduction to Masterclass in Oncology Nursing: Aims and objectives  
A. Margulies, CH - L. Sharp, SE - B. Grube, DK 

 15:00

Group introduction 

 15:30

Role development: Advanced oncology nursing practice 
B. Grube, DK

 16:00

Developing the evidence base for oncology nursing practice     
L. Sharp, SE

 16:30 Coffee break

 17:00

Clinical Trials - an overview
A. Margulies, CH

 17:30

Metastatic renal cancer: Evidence-based treatment
T. Eisen, UK 

 18:15

Group activity - Aims and directives         
A. Margulies, CH - L. Sharp, SE - B. Grube, DK

 19:30

Dinner

 

9 March

  8:30

Clinical session Gastro-intestinal tumours
Chair: D. Sebag-Montefiore, UK
 

Colon cancer: 

  • Adjuvant and neoadjuvant treatment of colorectal cancer 
    E. van Cutsem, BE
  • Systemic treatment in advanced disease (including liver)
    E. van Cutsem, BE

 10:00

Coffee break

 10:30

Clinical session Gastro-intestinal tumours II 
Chair: A. Cervantes, ES

 

  • Management of rectal cancer (surgery and radiotherapy) 
    D. Sebag-Montefiore, UK
  • Systemic treatment in early and advanced gastric cancer (including pancreas)
    A. Cervantes, ES
  • Pancreatic Cancer
    R. Popescu, CH

12:00

Case studies 1 Presentation and discussion 
L. Sharp, SE

 13:00

Lunch

 14:00

Nutrition problems and cancer   
TBC

 14:45

Spotlight session 2 Management of toxicity of new targeted drugs (including neuro-toxicity) (working title)     
M. Aapro, CH

 15:30

Spotlight session 3 Skin toxicity   
S. Segaert, BE

 16:00

Coffee break

 16:30

Community Nursing     
S. Faithfull, UK

17:30

Case studies 2 Presentation and discussion 
L. Sharp, SE

 19:30

Dinner 

 

10 March

   8:30

Clinical session Breast cancer I
Chair: G. Curigliano, IT

 

  • What the clinician needs to know about breast pathology
    G. Pruneri, IT
  • (Neo)Adjuvant chemotherapy and biological agents
    G. Curigliano, IT
  • (Neo)Adjuvant endocrine therapy
    O. Pagani, CH
  • Current controversies and challenges in breast surgery
    W. Gatzemeier, IT

 10:15

Coffee break

 10:40

Clinical session Breast cancer II 
Chair: O. Pagani, CH

 

  • Management of HER-2+ and triple negative advanced breast cancer  
    G. Curigliano, IT
  • Management of ER+ advanced breast cancer
    O. Pagani, CH
  • Standards and new techniques in breast radiotherapy
    J. Bernier, CH

 12:00

Case studies 3 Presentation and discussion  
L. Sharp, SE

 13:00Lunch 
 14:00

Prostate Cancer - Overview     
E. van Muilekom,NL

 15:00 

Patient Safety and Team Communication   
L. Sharp, UK
 15:45

Coffee break 

 16:15Radiotherapy - An overview and new developments 
L. Sharp, UK

 17:15

Targeted Therapy     
A. Margulies, CH

 18:15

Wrap up - days 1-3    
Participants

 19:30

Dinner 

 

11 March

  8:45

Physical Activity / Exercise and Cancer
J-M. Lüthi, CH

  10:00  

Spotlight session 8 Fertility Preservation  
F.A. Peccatori, IT

 10:30

Coffee break   

  11:00 

Research in Nursing    
M. Wells, UK

  12:00 

Teen-agers, adolescence and Cancer   
D. Kelly, UK

 13:00

Lunch

  14:15 

Market place     

 16:30

Free time

 19:00

Special evening

 

12 March

  8:30 

Clinical session Lung cancer and mesothelioma I
Chair: R. Stahel, CH

 

  • Surgery
    W. Weder, CH
  • Radiotherapy
    C. Faivre-Finn, UK
  • Non-small cell lung cancer systemic therapy                    
    R.A. Stahel, CH

 10:30

Coffee break

 11:00

Clinical session Lung cancer and mesothelioma II
Chair: R.A. Stahel, CH

 

  • Small cell lung cancer
    C. Faivre-Finn, UK
  • Mesothelioma
    R.A. Stahel, CH

 12:00

Case Studies 3 Presentation and discussion  
L. Sharp, SE

 13:00

Lunch

 14:00

Genetics and genetic counselling
G. Pichert, CH   

 15:30

Spotlight session 12 State of the art approaches to brain tumours     
M. Weller, CH

 16:00

Wrap up - days 4-5 

 16:30

Coffee break

 17:45

Learning assessment test 

 19:30

Dinner

 

13 March

 8:30

JOINT session MCO + MON I parallel sessions
(2 groups, each group attending both parts) 
GROUP A 
Introduction to Communication Skills - an interactive learning workshop
A. Arber, UK - A. Hoy, UK

GROUP B 
Facilitating patient adherence to oral cancer therapies 
C. Rothermundt, CH
Survivorship - challenges over time   
N. Aaronson,  NL

10:00

Coffee break

 10:30 

JOINT session MCO + MON II parallel sessions
(2 groups, each group attending both parts) 

GROUP B

Facilitating patient adherence to oral cancer therapies 
C. Rothermundt, CH
Survivorship - challenges over time   
N. Aaronson,  NL


GROUP A

Introduction to Communication Skills - an interactive Learning workshop
A. Arber, UK - A. Hoy, UK

12:00

Close
 

 

  

Follow us